To review studies of psychopharmacological management of aggression in common childhood psychiatric disorders.
Method:
Using OVID software, we searched Medline for studies that were undertaken in the last 30 years. Controlled and uncontrolled data are summarized for each condition.
Results:
A paucity of evidence-based information currently exists. Even so, specific indications from the existing literature can be suggested for several classes of psychotropics, particularly in conduct disorder (CD), attention-deficit hyperactivity disorder (ADHD), mood disorders, and other conditions.
Conclusions:
Clinicians can use findings from reviewed controlled and, where necessary, uncontrolled studies to inform pharmacologic practice. This review offers suggestions for future research directions that will aid clinical practice.
BassarathL.Conduct disorder: A biopsychosocial review. Can J Psychiatry2001;46:609–16.
2.
KazdinAE. Conduct disorder in childhood and adolescence. 2nd ed.Thousand Oaks (CA): Sage; 1995.
3.
FrickPJ. Effective interventions for children and adolescents with conduct disorder. Can J Psychiatry2001;46:597–608.
4.
ConnorDFSteingardRJ. A clinical approach to the pharmacotherapy of aggression in children and adolescents. Ann N Y Acad Sci1996;794:290–307.
5.
KazdinAE. Treatment of antisocial behaviour in children and adolescents. Homewood (IL): Dorsey; 1985.
6.
OffordDRBoyleMHFlemingJEBlumH MunroeRae-GrantNI. Ontario Child Health Study: Summary of selected results. Can J Psychiatry1989;34:483–91.
7.
Diagnostic and statistical manual of mental disorders. 4th ed.Washington (DC): American Psychiatric Association; 1994.
8.
FindlingRLMcNamaraNKBranickyLASchluchterMDLemonEBlumerJL. A double-blind pilot study of risperidone in treatment of conduct disorder. J Am Acad Child Adolesc Psychiatry2000;39:4:509–16.
9.
BuitelaarJK. Open-label treatment with risperidone of 26 psychiatrically hospitalized children and adolescents with mixed diagnoses and aggressive behavior. J Child Adolesc Psychopharmacol2000;10:19–26.
10.
CampbellMSmallAMGreenWHJenningsSJPerryRBennettWG, and others. Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder. Arch Gen Psychiatry1984;41:650–6.
11.
MaloneRPDelaneyMALuebbertJFCaterJCampbellM.A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder. Arch Gen Psychiatry2000;57:649–54.
12.
RifkinAKarajgiBDickerRPerlEBoppanaVHasanN, and others. Lithium treatment of conduct disorders in adolescents. Am J Psychiatry1997;154:554–5.
13.
KleinRG. Preliminary results: Lithium effects in conduct disorders. CME Syllabus and Proceedings Summary, Symposium 2. The 144th Annual Meeting of the American Psychiatric Association; 1991 May 11–16; New Orleans (LA). Washington (DC): American Psychiatric Association. p. 119–120.
14.
KafantarisVCampbellMPadron-GayolMVSmallAMLocascioJJRosenbergCR. Carbamazepine in hospitalized aggressive conduct disorder children: An open pilot study. Psychopharmacol Bull1992;28:193–9.
15.
CuevaJEOverallJESmallAMArmenterosJLPerryRCampbellM.Carbamazepine in aggressive children with conduct disorder: A double-blind and placebo-controlled study. J Am Acad Child Adolesc Psychiatry1996;35:480–90.
16.
DonovanSJStewartJWNunesEVStewartJWQuitkinFMParidesM.Divalproex treatment for youth with explosive temper and mood lability: A double-blind, placebo-controlled crossover design. Am J Psychiatry2000;157:818–20.
17.
GadowKDNolanEESverdJSprafkinJPaolicelliL.Methylphenidate in aggressive-hyperactive boys: I. Effects on peer aggression in public school settings. J Am Acad Child Adolesc Psychiatry1990;29:710–8.
18.
KleinRGAbikoffHKlassEGanelesDSeeseLMPollackS.Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Arch Gen Psychiatry1997;54:1073–80.
19.
CampbellMGonzalezNMSilvaRR. The pharmacologic treatment of conduct disorders and rage outbursts. Psychiatr Clin North Am1992;15:69–85.
20.
KemphJPDeVaneCLLevinGMJareckeRMillerRL. Treatment of aggressive children with clonidine: Results of an open pilot study. J Am Acad Child Adolesc Psychiatry1993;32:577–81.
21.
PettiTAFishBShapiroTCohenILCampbellM.Effects of chlordiazepoxide in disturbed children: A pilot study. J Clin Psychopharmacol1982;2:270–3.
22.
ZubietaJKAlessiNE. Acute and chronic administration of trazodone in the treatment of disruptive behavior disorders in children. J Clin Psychopharmacol1992;12:346–51.
23.
FrickPJ. Effective interventions for children and adolescents with conduct disorder. Can J Psychiatry2001;46:597–608.
24.
OffordDRBoyleMHRacineYA. The epidemiology of antisocial behavior in childhood and adolescence. In: PeplerDJRubinKH, editors. The development and treatment of childhood aggressionHillsdale (NJ): Lawrence Erlbaum; 1991. p 21–54.
25.
BiedermanJFaraoneSVLapeyK.Child and Adolescent Psychiatric Clinics of North America1992;1:335–60.
26.
BarkleyRA. Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment. 2nd ed.New York: Guilford Press; 1998.
27.
HinshawSPHenkerBWhalenCK. Self-control in hyperactive boys in anger-inducing situations: Effects of cognitive-behavioral training and of methylphenidate. J Abnorm Child Psychol1984;12:155–77.
28.
MatierKHalperinJMSharmaVNewcornJHSathayeN.Methylphenidate response in aggressive and nonaggressive ADHD children: Distinctions on laboratory measures of symptoms. J Am Acad Child Adolesc Psychiatry1992;31:219–25.
29.
WinsbergBGPressMBialerIKupietzS.Dextroamphetamine and methylphenidate in the treatment of hyperactive-aggressive children. Pediatrics1974;53:236–41.
30.
AmeryBMinichielloMDBrownGL. Aggression in hyperactive boys: Response to D-amphetamine. J Am Acad Child Psychiatry1984;23:291–4.
31.
HuntRDMinderaaRBCohenDJ. Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-crossover therapeutic trial. J Am Acad Child Psychiatry1985;24:617–29.
32.
ConnorDFBarkleyRADavisHT. A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Clin Pediatr2000;39:15–25.
33.
HuntRDArnstenAFAsbellMD. An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry1995;34:50–4.
34.
ClayTHGualtieriCTEvansRWGullionCM. Clinical and neuropsychological effects of the novel antidepressant bupropion. Psychopharmacol Bull1988;24:143–8.
35.
BiedermanJBaldessariniRJWrightVKneeDHarmatzJS. A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy. J Am Acad Child Adolesc Psychiatry1989;28:777–84.
36.
FindlingRL. Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: A case series. J Child Adolesc Psychopharmacol1996;6:165–75.
37.
BarrickmanLNoyesRKupermanSSchumacherEVerdaM.Treatment of ADHD with fluoxetine: A preliminary trial. J Am Acad Child Adolesc Psychiatry1991;30:762–7.
38.
OlveraRLPliszkaSRLuhJTatumR.An open trial of venlafaxine in the treatment of attention-deficit/hyperactivity disorder in children and adolescents. J Child Adolesc Psychopharmacol1996;6:241–50.
39.
PineDSKleinRGLindyDCMarshallRD. Attention-deficit hyperactivity disorder and comorbid psychosis: A review and two clinical presentations. J Clin Psychiatry1993;54:140–5.
40.
LewinsohnPMKleinDNSeeleyJR. Bipolar disorders in a community sample of older adolescents: Prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry1995;34:454–63.
41.
CarlsonGA. Clinical features and pathogenesis of child and adolescent mania. In: ShulmanKITohenMKutcherSP, editors. Mood disorders across the life span. New York: Wiley-Liss; 1996. p. 127–47.
42.
GellerBCooperTBSunKZimermanBFrazierJWilliamsM, and others. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry1998;37:171–8.
43.
WellerEBWellerRAFristadMA. Lithium dosage guide for prepubertal children: A preliminary report. J Am Acad Child Psychiatry1986;25:92–5.
44.
SadockBJKaplanVA. Pocket handbook of clinical psychiatry. 3rd ed.. Philadelphia: Lippincott Williams and Wilkins; 2001. p 275–305.
45.
DeltitoJALevitanJDamoreJHajalFZambenedettiM.Naturalistic experience with the use of divalproex sodium on an in-patient unit for adolescent psychiatric patients. Acta Psychiatr Scand1998;973:236–40.
46.
WestSAKeckPEMcElroySLStrakowskiSMMinneryKLMcConcilleBJ, and others. Open trial of valproate in the treatment of adolescent mania. J Child Adolesc Psychopharmacol1994;4:263–7.
47.
KutcherSP. Affective disorders in children and adolescents: A critical clinically relevant review. In: WalshBT, editor. Child psychopharmacology. American Psychiatric Association Review of Psychiatry. Volume 17. Washington (DC); APA; 1998. p 91–114.
48.
FrazierJAMeyerMCBiedermanJWozniakJWilensTESpencerTJ, and others. Risperidone treatment for juvenile bipolar disorder: A retrospective chart review. J Am Acad Child Adolesc Psychiatry1999;38:960–5.
49.
ScheierHA. Risperidone for young children with mood disorders and aggressive behaviour. J Child Adolesc Psychopharmacol1998;8:49–59.
50.
AngoldACostelloEJ. Depressive comorbidity in children and adolescents: Empirical, theoretical, and methodological issues. Am J Psychiatry1993;150:1779–91.
51.
KashaniJHDahlmeierJMBorduinCMSoltysSReidJC. Characteristics of anger expression in depressed children. J Am Acad Child Adolesc Psychiatry1995;34:322–6.
52.
TreutingJJHinshawSP. Depression and self-esteem in boys with attention-deficit/hyperactivity disorder: Associations with comorbid aggression and explanatory attributional mechanisms. J Abnorm Child Psychol2001;29:23–39.
53.
ConstantinoJNLibermanMKincaidM.Effects of serotonin reuptake inhibitors on aggressive behaviour in psychiatrically hospitalized adolescents: Results of an open trial. J Child Adolesc Psychopharmacol1997;7:31–44.
54.
ZubietaJKAlessiNE. Acute and chronic administration of trazodone in the treatment of disruptive behaviour disorders in children. J Clin Psychopharmacol1992:12:346–51.
55.
PfefferCrJiangHDomeshekLJ. Buspirone treatment of psychiatrically hospitalized prepubertal children with symptoms of anxiety and moderately severe aggression. J Child Adolesc Psychopharmacol1997;7:145–55.
56.
LewisDOLovelyRYeagerCDella FeminaD.Toward a theory of the genesis of violence: A follow-up study of delinquents. J Am Acad Child Adolesc Psychiatry1989;28:431–6.
57.
AllanERAlpertMSisonCECitromeLLauryGBermanI.Adjunctive nadolol in the treatment of acutely aggressive schizophrenic patients. J Clin Psychiatry1996;57:455–9.
58.
WilliamsDTMehlRYudofskySAdamsDRosemanB.The effect of propranolol on uncontrolled rage outbursts in children and adolescents with organic brain dysfunction. J Am Acad Child Psychiatry1982;21:129–35.
59.
FamularoRKinscherffRFentonT.Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study. Am J Dis Child1988;142:1244–7.
60.
Van BellinghenMDe TrochC.Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: A double-blind, placebo-controlled pilot trial. J Child Adolesc Psychopharmacol2001;11:5–13.
61.
SandorPStephensRJ. Risperidone treatment of aggressive behaviour in children with Tourette syndrome [letter]. J Clin Psychopharmacol2000;20:710–2.
62.
AndersonLTCampbellMAdamsPSmallAMPerryRShellJ.The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children. J Autism Dev Disord1989;19:227–39.
63.
JoshiPTCapozzoliJACoyleJT. Low-dose neuroleptic therapy for children with childhood-onset pervasive developmental disorder. Am J Psychiatry1988;145:335–8.
64.
GordonCTStateRCNelsonJHamburgerSDRapoportJL. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry1993;50:441–7.
